Robert Carey Biography and Net Worth

Director of Beyond Air

Robert F. Carey is Independent Director of the Company. Mr. Carey served as executive vice president, chief business officer for Horizon Pharma plc, a biopharmaceutical company, from March 2014 to October 2019. Prior to that, he served as managing director and head of the healthcare investment banking group at JMP Securities LLC, a full-service investment bank from March 2003 to March 2014. Prior to JMP, Mr. Carey was a managing director in the healthcare groups at Dresdner Kleinwort Wasserstein and Vector Securities International, Inc. He has also held roles at Shearson Lehman Hutton and Ernst & Whinney. Mr. Carey also serves on the board of directors of Beyond Air, Inc. (formerly AIT Therapeutics, Inc.). Mr. Carey received his B.S. in accounting from the University of Notre Dame. The Nominating and Corporate Governance Committee and the Board believe that Mr. Carey’s extensive experience and knowledge in the healthcare investment banking industry, particularly with financings, global expansion and other strategic transactions by life-science companies, as well as his role in business development for a public biopharmaceutical company, provides the Board with valuable insight and contribution.

What is Robert Carey's net worth?: The estimated net worth of Robert Carey is at least $1.19 million as of March 14th, 2025. Mr. Carey owns 4,076,864 shares of Beyond Air stock worth more than $1,193,298 as of March 25th. This net worth estimate does not reflect any other assets that Mr. Carey may own. Learn More about Robert Carey's net worth.
How do I contact Robert Carey?: The corporate mailing address for Mr. Carey and other Beyond Air executives is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. Beyond Air can also be reached via phone at (516) 665-8200 and via email at cdavis@lifesciadvisors.com. Learn More on Robert Carey's contact information.
Has Robert Carey been buying or selling shares of Beyond Air?: In the last ninety days, Robert Carey has bought $250,000.00 in shares of Beyond Air stock. Most recently, on Friday, March 14th, Robert Carey bought 1,000,000 shares of Beyond Air stock. The stock was acquired at an average cost of $0.25 per share, with a total value of $250,000.00. Following the completion of the transaction, the director now directly owns 4,076,864 shares of the company's stock, valued at $1,019,216. Learn More on Robert Carey's trading history.
Who are Beyond Air's active insiders?: Beyond Air's insider roster includes Amir Avniel (COO), Douglas Beck (CFO), Ron Bentsur (Director), Robert Carey (Director), and Steven Lisi (CEO). Learn More on Beyond Air's active insiders.
Are insiders buying or selling shares of Beyond Air?: In the last year, Beyond Air insiders bought shares 5 times. They purchased a total of 2,621,892 shares worth more than $1,045,299.40. The most recent insider tranaction occured on March, 14th when Director Robert Carey bought 1,000,000 shares worth more than $250,000.00. Insiders at Beyond Air own 20.1% of the company. Learn More about insider trades at Beyond Air.
Information on this page was last updated on 3/14/2025.

Robert Carey Insider Trading History at Beyond Air

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/14/2025	Buy	1,000,000	$0.25	$250,000.00	4,076,864
12/18/2023	Buy	1,200,000	$1.64	$1,968,000.00	2,374,454
8/28/2023	Buy	250,000	$2.69	$672,500.00	1,225,160
8/21/2023	Buy	75,050	$2.76	$207,138.00	975,160
8/18/2023	Buy	13,614	$2.64	$35,940.96	900,110
3/30/2023	Buy	10,000	$6.45	$64,500.00	886,496
3/13/2023	Buy	4,173	$6.15	$25,663.95	856,496
3/8/2023	Buy	10,000	$5.95	$59,500.00	852,323
12/7/2022	Buy	20,000	$5.75	$115,000.00	842,323
11/28/2022	Buy	15,000	$5.75	$86,250.00	807,323
11/18/2022	Buy	20,000	$5.80	$116,000.00	792,323
11/16/2022	Buy	10,000	$6.00	$60,000.00	752,323
6/30/2022	Buy	175,000	$6.45	$1,128,750.00	742,323
4/5/2022	Buy	20,000	$6.71	$134,200.00	567,323
3/24/2022	Buy	3,685	$6.58	$24,247.30
3/17/2022	Buy	20,000	$6.75	$135,000.00
12/22/2021	Buy	10,000	$9.50	$95,000.00
11/22/2021	Buy	10,000	$12.05	$120,500.00
11/19/2021	Buy	12,000	$14.10	$169,200.00
6/17/2021	Buy	350,000	$5.36	$1,876,000.00	481,418
3/4/2021	Buy	17,000	$5.70	$96,900.00	131,418
2/18/2021	Buy	15,000	$6.67	$100,050.00

See Full Table

Robert Carey Buying and Selling Activity at Beyond Air

Beyond Air Company Overview

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Today's Range

Now: $0.29

$0.29

$0.31

50 Day Range

MA: $0.34

$0.24

$0.44

2 Week Range

Now: $0.29

$0.24

$1.78

Volume

1,008,646 shs

Average Volume

1,446,377 shs

Market Capitalization

$20.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.16